9.30.09 Pediatrics Grand Rounds Evaluation
Exit this survey 

1. Finding Drug Safety Solutions to Serious Adverse Drug Reactions in Children

 
Bruce Carleton, PharmD
Director, Pharmaceutical Outcomes Programme
Children's and Women's Health Centre of British Columbia
Professor of Paediatrics and Pharmaceutical Sciences
University of British Columbia
Senior Clinician Scientists, Child and Family Research Institute
Vancouver, Canada
September 30, 2009

Objectives:
The participant will be able to:
1. Cite the areas in which pharmacogenomics have applications at the bedside
2. Identify ways pharmacogenomics are transforming practical clinical drug dosing strategies
3. List the barriers that remain to the advancement of bench to bedside care

1. How well did this lecture fulfill the stated objectives?

2. How current was the information presented?

3. Please rate the clinical applicability of the information presented.

4. Please rate the speaker's quality of presentation.

5. Was the presentation free of commercial bias?

6. Please use this space for general comments related to this presentation.

7. We welcome your suggestions for future topics.

Thank you for taking the time to complete this evaluation. Click the DONE button below to record your responses.